Abstract: Compounds of the formula I in which R, X, L2 and A1-A6 have the meanings indicated in Claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.

Abstract: An organic, optoelectronic component (10) is specified, comprising a three-dimensional substrate body (1), which has a closed substrate surface (1a), a radiation-emitting layer sequence (2), which has at least one layer (2a, 2b, 2c, 2d, 2e), containing an organic material, wherein the radiation-emitting layer sequence (2) is applied to the closed substrate surface (1a) and forms a curved area.

Abstract: Novel 7-azaindole derivatives of the formula (I), in which U, L, R, Y, X1, X2 and X3 have the meanings indicated in Claim (1), are kinase inhibitors and can be used for the treatment of diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in any type of fibroses, inflammatory processes, tumors and tumor diseases.

Abstract: Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having accounting functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described.

Abstract: A radiation-emitting device with a first electrode, a first emission layer, a second emission layer and a second electrode. The invention additionally relates to a method of producing a radiation-emitting device.

Abstract: Compositions containing (A) at least one silane-terminated polyether derivative with a content of polyether groups from 10 to 98% and a content of 1 to 25% terminal groups with the structure —NR1—X—Si(OR2)mR3(3-m)??(I) in which m denotes 1, 2 or 3 R1, R2, R3 independently of each other denote H or a saturated or unsaturated, linear, branched, cyclic or polycyclic hydrocarbon group with 0 to 10 heteroatoms from the group O, N, S and a total of 1 to 30 carbon atoms, X denotes a group with the empirical formula CnH2n, n denotes a whole number ?3, with the stipulation that n>3, if R1 stands for H, (B1) water and (B2) at least one organic or inorganic acid, as well as optional diluents and/or fillers and/or ordinary additives, are suitable for preparation of molding compounds, especially in the dental field.

Abstract: Novel oxadiazole derivatives of the formula (I), in which R, R?, Y, X1, X2 and X3 have the meanings indicated in claim 1, are kinase inhibitors and can be used for the treatment of diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, in general in all types of fibroses, inflammatory processes, tumours and tumour diseases.

Abstract: An embodiment of the invention concerns a light-emitting device with an adjustable, time-variable luminance. This is achieved through electrically conductive tracks that are applied to the first electrode area. The conductive tracks are driven in a time-variable manner with different levels of electrical power.

Abstract: A spray head (1) with a nozzle insert (2) for atomizing a fluid, which tends to gum up or harden, from a reservoir, wherein the nozzle insert (2) is substantially designed as a hollow cylinder (3) that is open on one side and has, on the other side, a nozzle opening (4) towards the outside, and the nozzle insert (2) is connected to a nozzle insert receptacle (5), which has a channel (6) for the fluid, wherein the channel (6) corresponds to the nozzle opening (4). The nozzle insert (2) consists of an elastic material (7) and, in this manner, is connected to the nozzle insert receptacle (5) so that an external, free section (8) of the nozzle insert (2) along with the nozzle opening (4) is at least partially manually compressible and/or is designed to be manually bendable from its standby position (R), whereby hardened resin residue (12) can be removed from the nozzle opening (4).

Abstract: Novel heterocyclic indazole derivatives of the formula (I), in which L, Q, R, X, Y, R3, R4 and R5 have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.

Abstract: An organic luminous means and an illumination device comprising such a luminous means are described. An optical display apparatus, emergency lighting, motor vehicle interior lighting, an item of furniture, a construction material, a glazing and a display comprising such a luminous means and, respectively, comprising an illumination device having such a luminous means are also described.

Abstract: An electroluminescent organic semiconductor element includes a substrate and a first electrode arranged on the substrate. The semiconductor element additionally contains a second electrode and at least one organic layer, which is arranged between the first electrode and the second electrode. The organic layer is a layer that generates light by recombination of charge carriers. At least one of the first and the second electrode contains a highly conductive organic sublayer.

Abstract: An optoelectronic device comprises an organic layer sequence (1), which emits an electromagnetic radiation (15) having a first wavelength spectrum during operation, and also a structured layer (2) which is disposed downstream of the organic layer sequence (1) in the beam path of the electromagnetic radiation (15) emitted by the organic layer sequence (1) and has first and second regions (2A, 2B). In this case, the first regions (2A) each have a wavelength conversion layer (3) designed to convert at least partially electromagnetic radiation (15) having the first wavelength spectrum into an electromagnetic radiation (16) having a second wavelength spectrum. Furthermore, the second regions (2B) each have a filter layer (4), which is opaque to an electromagnetic radiation having a third wavelength spectrum, which corresponds to at least one part of the second wavelength spectrum.

Abstract: A radiation-emitting arrangement comprises, in particular, a carrier element (1) having an at least partly non-transparent main surface (10) and arranged on the carrier element (1), an organic radiation-emitting component (2) having an organic layer sequence (23) with an active region between an at least partly transparent first electrode (21) and an at least partly transparent second electrode (22). The active region (29) is suitable for generating electromagnetic radiation (91, 93) in a switched-on operating state. The radiation-emitting arrangement has a radiation exit area (3) for emitting the electromagnetic radiation (92, 93) on that side of the organic radiation-emitting component (2) which faces away from the carrier element. (1) The at least partly non-transparent main surface (10) of the carrier element (1) is perceptible by an external observer through the radiation exit area (3) in a switched-off operating state of the organic radiation-emitting component (2).

Abstract: Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5, R6 and X7 have the meanings indicated in Patent Claim 1, are suitable as antidiabetics.

Abstract: Novel compounds of the formula I, in which X, Y, R, R?, R1, R1?, R1?, R2, R2?, R2?, R3, R3?, R4, R4? and n have the meanings indicated in Patent Claim 1, are suitable as antidiabetics

Abstract: Compounds of the formula (I), in which X1, X2, L, Y, R2, R3, R4, R5, R6, R7, R8, R9, R10 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.

Abstract: A radiation-emitting device has a radiation-emitting component with a layer stack with an active region that is formed for the emission of electromagnetic radiation. A microstructure layer is mechanically coupled to the layer stack and has elevations that extend away from the layer stack. A protective layer has a planar side facing away from the microstructure layer and is arranged on a side of the microstructure layer facing away from the layer stack.

Abstract: Compounds of the formula (I), in which X, R1 and R2 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.

Abstract: A radiation emitting device includes a substrate and a layer sequence disposed on top of the substrate. The layer sequence includes a first electrode surface with a first contact for applying a voltage, at least one functional layer that emits radiation during operation, and a second electrode surface. In the layer sequence, a plurality of partial regions is present that is modified in such a way that the emission of radiation visible to an external observer therefrom is interrupted. The distribution density of these partial regions can vary depending on their distance from the contact.